# Clinical Cases: Control of Breathing

## Case 1: Opioid Overdose with Respiratory Depression

### Clinical Image
![Opioid overdose presentation](case_01_image.jpg)
*Source: [Wikimedia Commons - Opioid Overdose](https://commons.wikimedia.org/wiki/File:Opioid_overdose_patient.jpg) - CC BY 4.0*

### Case Presentation
A 28-year-old man is found unresponsive by his roommate in their apartment. Empty pill bottles of oxycodone are found nearby. Emergency medical services are called and find the patient with pinpoint pupils, respiratory rate of 4 breaths/min, shallow tidal volume, and oxygen saturation of 72% on room air. He is unresponsive to verbal and painful stimuli.

Arterial blood gas on room air shows pH 7.18, PaCO2 82 mmHg, PaO2 45 mmHg, HCO3 26 mEq/L. The calculated A-a gradient is normal at 8 mmHg (expected PAO2 from alveolar gas equation with PCO2 of 82 is approximately 53 mmHg).

This case demonstrates acute hypercapnic respiratory failure from central respiratory depression. Opioids act on mu-receptors in the brainstem respiratory centers (pre-Botzinger complex, medullary respiratory groups) to suppress the ventilatory response to carbon dioxide. The CO2 response curve is shifted rightward, meaning higher CO2 levels are required to stimulate breathing. At high opioid doses, the respiratory centers are so depressed that even markedly elevated CO2 fails to stimulate adequate ventilation.

The normal A-a gradient confirms that gas exchange is intact; the problem is purely ventilatory (pump failure). The hypoxemia is secondary to hypoventilation, as described by the alveolar gas equation: when PaCO2 rises dramatically, PAO2 must fall proportionally.

The patient receives intranasal naloxone 4 mg by EMS, followed by IV naloxone 0.4 mg in the emergency department. Within minutes, his respiratory rate increases to 14/min, pupils dilate, and he regains consciousness. Repeat ABG shows pH 7.38, PaCO2 42 mmHg, PaO2 92 mmHg. He is monitored for recurrence of respiratory depression (given opioid half-life exceeds naloxone half-life) and counseled on opioid use disorder.

### Key Learning Points
- Opioids depress brainstem respiratory centers, shifting the CO2 response curve rightward
- Hypercapnia develops because the ventilatory response to rising CO2 is blunted
- The A-a gradient remains normal in hypoventilation because gas exchange is intact
- Hypoxemia in hypoventilation is explained by the alveolar gas equation
- Naloxone rapidly reverses opioid-induced respiratory depression by competitive mu-receptor antagonism

---

## Case 2: Cheyne-Stokes Respiration in Heart Failure

### Case Presentation
A 72-year-old man with severe heart failure (ejection fraction 20%) is admitted for decompensation. His wife reports that at night, his breathing stops for 15-20 seconds, then gradually becomes deeper and faster, then shallow again before stopping - a pattern that repeats throughout the night. She has observed this pattern worsening over the past several months.

Overnight polysomnography confirms Cheyne-Stokes respiration with central sleep apnea. The pattern shows regular cycles of crescendo-decrescendo breathing with central apneas lasting 15-25 seconds. The apnea-hypopnea index is 42 events per hour. Arterial blood gas shows pH 7.46, PaCO2 32 mmHg, PaO2 78 mmHg, indicating chronic respiratory alkalosis.

Cheyne-Stokes respiration results from instability in the respiratory control feedback loop, most commonly due to prolonged circulation time in severe heart failure. In normal individuals, changes in ventilation rapidly affect blood gases sensed by chemoreceptors, allowing tight feedback control. In heart failure, blood takes longer to travel from the lungs to the chemoreceptors (carotid bodies and central chemoreceptors), creating a phase delay.

When the patient hyperventilates in response to perceived hypercapnia, the resulting hypocapnia does not reach the chemoreceptors until many seconds later. By that time, excessive hypocapnia develops, and when finally sensed, triggers apnea. During apnea, CO2 rises, but this is not sensed until circulation time later, leading to overshoot hyperventilation. This oscillating pattern continues in a waxing-waning cycle.

The patient is treated with optimization of heart failure therapy. Nocturnal supplemental oxygen is provided, which blunts the hypoxic ventilatory response and reduces loop instability. Adaptive servo-ventilation (ASV), a form of positive pressure ventilation that automatically adjusts support to stabilize breathing, would have been considered but is contraindicated in patients with severely reduced ejection fraction. The patient reports improved sleep quality with nocturnal oxygen.

### Key Learning Points
- Cheyne-Stokes respiration is caused by instability in the respiratory control feedback loop
- Prolonged circulation time in heart failure creates phase delay between ventilatory changes and chemoreceptor sensing
- The pattern shows regular crescendo-decrescendo breathing with periodic apneas
- Chronic respiratory alkalosis is common due to overall hyperventilation during the hyperpneic phases
- Treatment includes optimizing heart failure and providing nocturnal oxygen

---

## Case 3: Obesity Hypoventilation Syndrome

### Case Presentation
A 52-year-old woman with BMI 48 kg/m2 presents with progressive daytime somnolence, morning headaches, and lower extremity edema. She has a history of obstructive sleep apnea diagnosed 5 years ago but has been non-adherent with CPAP therapy. On examination, she is obese and plethoric with elevated jugular venous pressure, lower extremity edema, and a loud P2. Vital signs show respiratory rate 16/min, heart rate 92 bpm, blood pressure 155/95 mmHg, and oxygen saturation 84% on room air.

Arterial blood gas on room air shows pH 7.35, PaCO2 58 mmHg, PaO2 52 mmHg, HCO3 32 mEq/L. Serum bicarbonate is elevated at 34 mEq/L. The elevated bicarbonate with near-normal pH indicates chronic respiratory acidosis with metabolic compensation. Echocardiogram shows right ventricular hypertrophy and elevated pulmonary artery pressures consistent with cor pulmonale.

This patient has obesity hypoventilation syndrome (OHS), characterized by obesity (BMI greater than 30), chronic daytime hypercapnia (PaCO2 greater than 45 mmHg), and sleep-disordered breathing, after excluding other causes of hypoventilation. The pathophysiology involves multiple factors: increased work of breathing from chest wall loading and decreased compliance; reduced central chemosensitivity to CO2 (possibly from leptin resistance); and upper airway obstruction during sleep.

The chronic hypercapnia leads to renal bicarbonate retention to maintain pH near normal - this is the expected compensation for chronic respiratory acidosis (3.5 mEq/L increase in HCO3 for each 10 mmHg rise in PCO2). The chronic hypoxemia causes pulmonary vasoconstriction and eventually pulmonary hypertension with cor pulmonale.

Treatment includes positive airway pressure therapy (CPAP or BiPAP depending on severity), weight loss, and management of comorbidities. The patient is started on nocturnal BiPAP and improves significantly over several months with resolution of morning headaches and improved daytime alertness.

### Key Learning Points
- Obesity hypoventilation syndrome requires obesity, chronic daytime hypercapnia, and sleep-disordered breathing
- Chronic hypercapnia leads to renal bicarbonate retention with near-normal pH (compensated respiratory acidosis)
- Elevated bicarbonate further blunts the central chemoreceptor response to CO2
- Chronic hypoxemia causes pulmonary hypertension and cor pulmonale
- Positive airway pressure therapy is the cornerstone of treatment